Rejuvenating the applications of collagen

Applying nanotechnology to unlock the potential of collagen in tissue repair and regenerative medicine.

EternoGen uniquely combines the most natural and pure biomaterial with platform nanotechnology to produce Advanced Collagen Replenishment Therapy. The natural open microstructure of collagen is shielded from enzymatic degradation, forming a highly biocompatible matrix for cellular integration and regeneration which lasts up to twice as long as current options.

EternoGen Featured in University Alumni Magazine

Mizzou Alumni Magazine: A product developed at MU could revolutionize the aesthetic medicine market. Backed by MU research, the biotech startup EternoGen is preparing two collagen-based dermal fillers to treat facial wrinkles. One of the products employs gold nanoparticles and has medical applications beyond aesthetics. Story by Erik Potter

Anna Tenstam Lundvall to assume the position of CEO of EternoGen LLC

EternoGen announced today that Anna Tenstam Lundvall will be assuming the position of Chief Executive Officer effective immediately. Lundvall, who has chaired EternoGen’s board for the past 3 years, will take over from Luis Jimenez who will fill the position of President & Chief Operating Officer.

EternoGen features in the industry leading PRIME Journal following IMCAS presentations

At this year’s IMCAS Paris congress, collagen was firmly back on the agenda as start-up company EternoGen LLC unveiled its Advanced Collagen Replenishment portfolio